Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.

Diabetes care - 1 May 2024

Cahill Leah E, Warren Rachel A, Carew Allie S, Levy Andrew P, Sapp John, Samuel Michelle, Selvin Elizabeth, Lavallée Samantha K, Poulter Neil, Marre Michel, Harrap Stephen, Mancia Giuseppe, Harris Katie, Chalmers John, Woodward Mark, Rimm Eric B

Abstract excerpt

OBJECTIVE: Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study participants with the haptoglobin (Hp)2-2 phenotype but not in participants without the Hp2-2 phenotype. It is unknown whether and how these results translate across different demographic/clinical characteristics and treatment strategies. RESEARCH DESIGN AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Diabetes Mellitus, Type 2

Share to Haptoglobins

Share to Phenotype

Share to Risk Factors

Share to Risk Reduction Behavior

Source

Open in PubMed Open full text

Identifiers

PMID: 38484336
DOI: 10.2337/dc23-2165
PMCID: PMC11835605

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.PMID 38484336Read ↗

Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.Semantic proximity Read ↗

Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study.Semantic proximity Read ↗

The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants.Semantic proximity Read ↗

The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study.Semantic proximity Read ↗

Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT.Semantic proximity Read ↗

Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.Semantic proximity Read ↗

Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.Semantic proximity Read ↗

Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study.Semantic proximity Read ↗

Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).Semantic proximity Read ↗

Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.Semantic proximity Read ↗

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia TreatmentSemantic proximity Read ↗

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.